Dr. Miller provides scientific rationale and clinical examples of a treatment modality that includes the combined use of adipose stem cells and platelet rich plasma (42:58 minutes).
In the past decades there has been an increasing interest for TEG in clinical practice. In this paper we present the rationale for the method and a discussion of the possible application of TEG.
By applying the numerous reported blood conservation strategies for the management of patients presenting for cardiac surgery, we can preserve our dwindling blood resources and help alleviate some of the direct costs of blood as well as the indirect costs of treating noninfectious and infectious complications of transfusion.